Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma

British Journal of Surgery

Volumn 96, Issue 7, 2009, Pages 724-733

  Peters, C J ^a,b   Hardwick, R H ^b   Vowler, S L ^c   Fitzgerald, R C ^a,b  

^a HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME;

EID: 67650021211     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6584     Document Type: Article

References (35)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252.
2. Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002; 102: 422-427.
3. Younes M. Is the incidence of esophageal adenocarcinomas in patients with Barrett's esophagus really overestimated? Gastroenterology 2005; 129: 2125-2126.
4. Cancer Research UK. Cancer Stats, 2006; http://info. cancerresearchuk.org/cancerstats/ [accessed 6 June 2007].
5. Sobin LH, Wittekind C (eds). TNM Classification of Malignant Tumours (6th edn). John Wiley: New York, 2002.
6. Mapstone NP. Dataset for the Histopathological Reporting of Oesophageal Carcinoma (2nd edn). Royal College of Pathologists: London, 2007.
7. American Joint Committee on Cancer. Collaborative Staging Task Force of the American Joint Committee on Cancer, version 01.03.00. American Joint Committee on Cancer and US Department of Health and Human Services: Chicago and Bethesda, 2006.
8. Hardwick RH, Williams GT. Staging of oesophageal adenocarcinoma. Br J Surg 2002; 89: 1076-1077.
9. Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549-555.
10. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-1459.
11. Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 2006; 15: 751-764.
12. Hölscher AH, Bollschweiler E, Bumm R, Bartels H, Höfler H, Siewert JR. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995; 118: 845-855.
13. Korst RJ, Rusch VW, Venkatraman E, Bains MS, Burt ME, Downey RJ et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998; 115: 660-669.
14. Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006; 132: 1374-1381.
15. Bollschweiler E, Baldus SE, Schröder W, Schneider PM, Hölscher AH. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol 2006; 94: 355-363.
16. Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 2006; 24: 4347-4355.
17. Aurello P, D'Angelo F, Nigri G, Bellagamba R, Cicchini C, Ruzzetti R et al. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review. Am Surg 2006; 72: 118-123.
18. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81: 410-413.
19. Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Bernini M et al. Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system. Ann Surg Oncol 2006; 14: 299-305.
20. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 2006; 106: 1017-1025.
21. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma (2nd English edn). Gastric Cancer 1998; 1: 10-24.
22. Kaplan E, Meier P. Non-parametric estimator from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
23. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
24. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis Part III: multivariate data analysis - choosing a model and assessing its adequacy and fit. Br J Cancer 2003; 89: 605-611.
25. R Development Core Team. R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, 2007.
26. Everitt B, Hothorn T. A Handbook of Statistical Analyses Using R. CRC Press: Boca Raton, 2006.
27. Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 2006; 15: 651-674.
28. Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part IV: further concepts and methods in survival analysis. Br J Cancer 2003; 89: 781-786.
29. Thompson SK, Ruszkiewicz AR, Jamieson GG, Wijnhoven BP, Watson DI, Devitt PG. HP37. Prognostic factors in oesophageal cancer: number of lymph nodes and extracapsular lymph node invasion - an interim analysis. ANZ J Surg 2007; 77: A48.
30. Nigro JJ, DeMeester SR, Hagen JA, DeMeester TR, Peters JH, Kiyabu M et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999; 117: 960-968.
31. Seto Y, Fukuda T, Yamada K, Matsubara T, Hiki N, Fukunaga T et al. Celiac lymph nodes: distant or regional for thoracic esophageal carcinoma? Dis Esophagus 2008; 21: 704-707.
32. Puli SR, Reddy JB, Bechtold ML, Antillon MR, Ibdah JA. Accuracy of endoscopic ultrasound in the diagnosis of distal and celiac axis lymph node metastasis in esophageal cancer: a meta-analysis and systematic review. Dig Dis Sci 2007; 53: 2405-2415.
33. Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001; 48: 667-670.
34. Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM. The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol 2006; 32: 413-419.
35. Khan OA, Fitzgerald JJ, Soomro I, Beggs FD, Morgan WE, Duffy JP. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer 2003; 88: 1549-1552.